title: Cardiovascular MR imaging in cardio-oncology.
abstract: Patients with cancer are subject to short-term and long-term adverse cardiovascular outcomes from cancer therapies. It is important to identify patients at risk for cardiotoxicity so that appropriate therapy can be instituted early. Cardiovascular magnetic resonance (MR) imaging is emerging as a promising imaging modality with unique applications beyond standard left-ventricular systolic function assessment. It can provide comprehensive evaluation of most cardiac structures in one setting. This article provides an overview of cardiac MR imaging in cardio-oncology.
authors.affiliation: Division of Cardiology, University of Minnesota Medical Center, 420 Delaware Street Southeast MMC 508, Minneapolis, MN 55455, USA.
authors.forename: Ashenafi M
authors.initials: AM
authors.lastname: Tamene
authors.affiliation: Division of Cardiology, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195, USA.
authors.forename: Carolina
authors.initials: C
authors.lastname: Masri
authors.affiliation: Division of Cardiology, University of Minnesota Medical Center, 420 Delaware Street Southeast MMC 508, Minneapolis, MN 55455, USA. Electronic address: shkonety@umn.edu.
authors.forename: Suma H
authors.initials: SH
authors.lastname: Konety
mesh_terms: D006338:Heart Neoplasms / Q000150:complications / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D018487:Ventricular Dysfunction, Left / Q000209:etiology / Q000473:pathology* / Q000628:therapy*
keywords: Cardio-oncology; Cardiotoxicity; Cardiovascular magnetic resonance imaging; Radiation-induced heart disease